Semaglutide slows gastric emptying, which can increase stomach pressure and volume, potentially promoting reflux of gastric contents into the esophagus
Joseph is a 2023 Castle Connolly Top Doctor and is co-chair of The Ohio State University Wexner Medical Center Obesity and Nutrition Steering Committee
GLP-1 and GLP-1/GIP medications are approved to treat type 2 diabetes mellitus, obesity, and metabolic dysfunction-associated steatohepatitis (MASH) with added benefits in patients with cardiovascular disease and renal disease [4, 5]
Experts now envision a future where medications, minimally invasive procedures, surgery, and precision medicine work together to deliver better long-term results
The 2-day rule, explained Semaglutide has an elimination half-life of approximately 7 days, confirmed by a population pharmacokinetic analysis of 1,612 patients across five Phase III trials (Carlsson Petri et al., 2018, Diabetes Therapy )
Use the formula: units = (prescribed mg / concentration mg per mL) x 100
